High Uptake of HIV Testing in Pregnant Women in Ontario, Canada

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Remis, Robert S ^a   Merid, Maraki Fikre ^a   Palmer, Robert W H ^a   Whittingham, Elaine ^a   King, Susan M ^b   Danson, Natasha S ^a   Vernich, Lee ^a   Swantee, Carol ^c   Major, Carol ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c PUBLIC HEALTH ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RATE; PREGNANCY OUTCOME; PREGNANCY RATE; PREGNANT WOMAN; PRENATAL CARE; PRENATAL EXPOSURE; VIRUS IDENTIFICATION;

ADOLESCENT; ADULT; COUNSELING; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; ONTARIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; YOUNG ADULT;

EID: 84869002028     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048077     Document Type: Article

References (22)

1. Coates RA, Frank JW, Arshinoff R, Major C, Wallace E, et al. (1992) The Ontario HIV seroprevalence study of childbearing women: results from the first year of testing. Clin Invest Med 5: 1-7.
2. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, et al. (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331: 1173-1180.
3. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada (1998) Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, 1998 (with 2000, 2002, 2005 amendments).
4. Federal Centre for AIDS Working Group on Anonymous Unlinked HIV Seroprevalence Research (1992) Revised guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. CMAJ 146: 1743-1746.
5. Boxall EH, (2004) Smith (2004) Antenatal screening for HIV: Are those who refuse testing at higher than those who accept testing. J Public Health 26: 285-287.
6. The Health Protection Agency (2003) HIV and other sexually transmitted infections in the United Kingdom in 2004. Annual report, November 2003 Unlinked Anonymous Prevalence Monitoring Programme: Unlinked Surveys of Pregnant women. Available: http://www.hpa.org.uk/hpa/publications/hiv_sti_2005/default.htm. Accessed 2006 May 23.
7. Plitt SS, Singh AE, Lee BE, Preiksaitis JK, (2007) HIV seroprevalence among women opting out of prenatal HIV screening in Alberta, Canada: 2002-2004. Clin Infect Dis 45: 1640-1643.
8. Jayaraman GC, Preiksaitis JK, Larke B, (2003) Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: Effect on testing rates. CMAJ 168: 679-682.
9. Gruslin A, Salvador A, Dekker M, Menard-de Varennes D, Eason E, (2001) Prenatal HIV screening in a tertiary care centre. Can J Public Health 92: 255-258.
10. Ogilvie G, Adsett S, Macdonald G, (1997) Do physicians discuss HIV testing during prenatal care? Can Fam Physician 43: 1376-1381.
11. Poulin C, Alary M, (1998) What was the medical practice regarding prenatal HIV testing before the Quebec intervention program on HIV infection and pregnancy? 7th Annual Conference of the Canadian Association for HIV/AIDS Research, Quebec, Quebec, Canada, May 1998 (Abstract 202). Can J Infect Dis 9: 28A.
12. MacDonald SE, Hartling LA, Seguin RM, O'Connor KS, Rekart ML, et al. (2001) Screening for HIV during pregnancy. Survey of physicians' practices. Can Fam Physician 47: 2250-2257.
13. O'Connor KS, MacDonald SE, Hartling L, Seguin RM, Hollands H, et al. (2002) The influence of prevalence and policy on the likelihood that a physician will offer HIV screening in pregnancy. Can J Public Health 93: 31-35.
14. Bitnun A, King SM, Arneson C, Read SE, (2002) Failure to prevent perinatal HIV infection. CMAJ 166: 904-905.
15. Boucher M, Samson J, Lapointe N, (2002) HIV screening among pregnant women in the province of Quebec: success and failure. 11th Annual Conference of the Canadian Association for HIV/AIDS Research, Winnipeg, Canada, April 2002 (Abstract 223). Can J Infect Dis 13: 30A.
16. Guenter D, Carroll J, Kaczorowski J, Sellors J, (2003) Prenatal HIV testing in Ontario: Knowledge, attitudes and practices of prenatal care providers in a province with low testing rates. Can J Public Health 94: 93-97.
17. Guenter D, Kaczorowski J, Sellors J, Carroll J, (2003) Prenatal HIV tests: Routine testing or informed choice? Can Fam Physician 49: 1334-1340.
18. Wang FL, Larke B, Gabos S, Hanrahan A, Schopflocher D, (2005) Potential factors that may affect acceptance of routine prenatal HIV testing. Can J Public Health 96: 60-64.
19. Yudin MH, Moravac C, Shah RR, (2007) Influence of an opt-out test strategy and patient factors on human immunodeficiency virus screening in pregnancy. Obstet Gynecol 110: 81-86.
20. Centers for Disease Control and Prevention (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Mortal Morbid Weekly Rep 55 (No.RR-14): 8-10.
21. Hughes CA, Zuk D, Foisy M, Robinson J, Singh AE, et al. (2010) Response to letter. Amer J Public Health 100: 389.
22. Sansom SL, Jamieson DJ, Farnham PG, Bulterys M, Fowler MG, (2003) Human immunodeficiency virus retesting during pregnancy: Costs and effectiveness in preventing perinatal transmission. Obstet Gynecol 192 (4): 782-790.